Caricamento...
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma
Glioblastoma (GBM) is a challenging diagnosis with almost universally poor prognosis. Though the survival advantage of postoperative radiation (RT) is well established, around 90% of patients will fail in the RT field. The high likelihood of local failure suggests the efficacy of RT needs to be impr...
Salvato in:
| Pubblicato in: | Neurooncol Pract |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7274183/ https://ncbi.nlm.nih.gov/pubmed/32537176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz057 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|